Roland Meisel, Ph.D. Email & Phone Number

BLAC-BioPharma GmbH is a consultancy supporting companies in out- and in-licensing of Biologics with a focus on Biosimilars having a worldwide network of companies developing Biologics including Biosimilars as well as looking to in-license. BLAC is backed by partner companies like The Biosimilars Group as a group of experts in all core competences needed to develop a Biosimilar from sourcing and sequencing of an originator until market application. Further to this BLAC is backed by a partner for Corporate Finance Services as well as other expert consultants supporting the building of facilities, the development of processes as well as protein and production quality assessment and assurance.Most of the services and experts in the BLAC network are not limited to Biosimilars. New Biological Entities, Bioprocessing Technologies and other BioPharma projects can be handles likewise especially in supporting Series A and B financing or M&A.Do not hesitate to send a message, if any of the above mentioned is of interest to you!

Weissknight works with and for business owners, entrepreneurs and CEOs to grow the value of their company.All our services are using a unique cross-border process and an underlying Big-Data analytics' technology, to successfully manage international M&A transactions, raise debt and capital (from venture capital, private equity, family offices and hedge funds), and pursue business optimisation strategies in order to maximise exit valuation, as well as to recruit the best senior talents to achieve the goal of shareholder value-creation.As Health-Care Partner of Weissknight, Roland is responsible for bringing scientific and technical Expertise into Weissknights value focused Services.

Zhuhai, Guangdong, Cn

ex-China responsibility for in- and out-licensing, technology scouting and co-development agreements / alliances

I have been responsible for technical operations in the design phase of SBMC covering equipment selection and preparation of equipment ordering, selection of set-ups and feasibility for serialization technology, for port for facility design and construction including utilities as well as supporting the construction and installation project for an aseptic filling unit with an automatic aseptic filling line intended for commercial supply.

Assigned for the global Business Development responsibility with The Biosimilar Group. The Biosimilars Group is an alliance of 5 service providers, each with its solid core competence, dedicated to the global development of biosimilars from candidate identification to marketed product.

as representative of Celonic AG, Partner within the TBG

Basel, Ch

Basel, Ch

Bergisch Gladbach, North Rhine-Westphalia, De

I was responsible for organizing product development of the apheresis system TheraSorb with LIFE18

I was responsible for organizing product development of the apheresis system TheraSorb with LIFE18

Being hired as Business Analyst I worked at client site rather as Consultant. I managed the project during my last client engagement on my own with little guidance by a Principal colleague.

Phd, Chemistry

Graduate Student, Carbohydrate Chemistry At The Whistler Center For Carbohydrate Research